Boudes Pol F 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 31, 2019
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-01-29+138,312→ 138,312 totalExercise: $8.43Exp: 2029-01-28→ Common Stock (138,312 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the underlying shares on January 1, 2020, and vests as to 1/48 of the underlying shares monthly thereafter.